2012
DOI: 10.4097/kjae.2012.62.2.161
|View full text |Cite
|
Sign up to set email alerts
|

Effect of manassantin B, a lignan isolated fromSaururus chinensis, on lipopolysaccharide-induced interleukin-1β in RAW 264.7 cells

Abstract: BackgroundElevated systemic levels of pro-inflammatory cytokines cause hypotension during septic shock and induce capillary leakage in acute lung injury. Manassantin B has anti-inflammatory and anti-plasmoidal properties. This study examined the effects of manassantin B on lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages.MethodsRAW 264.7 macrophage cells were incubated without or with (1, 3 and 10 µM) manassantin B and without or with (100 ng/ml) LPS. Manassantin B dissolved in phos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…These include the nuclear factor -light-chain-enhancer of activated B cells (NF-B) (3)(4)(5)(6) and CCAAT/enhancer-binding protein ␤ transcription factors (7), the mitogen-activated protein kinase (MAPK) (6,8,9), interleukin 6 -induced signal transducer and activator of transcription 3 (STAT3) (10), and hypoxia-inducible factor 1␣ (HIF-1␣) 2 (11)(12)(13). Some of these "molecular targets" were observed only in selected cell lines (7,8,10). It is unclear whether these biochemically diverse molecules or pathways are direct targets of manassantin or secondary cellular responses.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…These include the nuclear factor -light-chain-enhancer of activated B cells (NF-B) (3)(4)(5)(6) and CCAAT/enhancer-binding protein ␤ transcription factors (7), the mitogen-activated protein kinase (MAPK) (6,8,9), interleukin 6 -induced signal transducer and activator of transcription 3 (STAT3) (10), and hypoxia-inducible factor 1␣ (HIF-1␣) 2 (11)(12)(13). Some of these "molecular targets" were observed only in selected cell lines (7,8,10). It is unclear whether these biochemically diverse molecules or pathways are direct targets of manassantin or secondary cellular responses.…”
mentioning
confidence: 99%
“…Moreover, it remains unknown how these effectors contribute to the broad spectrum of medical benefits of manassantin seen in humans. Systematic screening via large-scale protein folding and stability measurements identified a number of hits that did not significantly overlap with those found from random cell-based analyses (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(15)(16)(17)(18)(19)(20).…”
mentioning
confidence: 99%
“…MB, a neolignan isolated from the roots of S. chinensis, has been demonstrated to exhibit a range of activities, including anti-inflammatory (10,(19)(20)(21), antiseptic (22) and antitumor activities (11,23). Furthermore, MB was shown to inhibit PMA-induced ICAM-1 expression in HL-60 cells (15) and to prevent monocyte adhesion to HUVECs through the inhibition of ICAM-1, VCAM-1 and E-selectin expression stimulated by TNF-α (24).…”
Section: Discussionmentioning
confidence: 99%
“…Manassantin B (MB) is a neolignan constituent of the roots of Saururus chinensis, which is used in the treatment of gonorrhea, edema, and jaundice in Korean traditional medicine [13]. According to previous studies, MB exerts anti-tumor [14,15], anti-inflammatory [16,17], anti-melanogenic [18,19], anti-human immunodeficiency virus [20], and anti-obesity [21,22] activities. In addition, MB exhibits an anti-tumor effect by inhibiting cell aggregation via the inhibition of phorbol 12-myristate 13-acetate-induced intercellular cell adhesion molecule-1 expression in HL-60 cells [14].…”
Section: Introductionmentioning
confidence: 99%